Thimble Point Acquisition Corp. (THMA) Shareholders Approve Pear Therapeutics Deal

Thimble Point Acquisition Corp. (NASDAQ:THMA) announced in an 8-K filing today that it secured shareholder approval of its combination with digital treatment provider Pear Therapeutics in a special meeting today. Although Thimble Point did not disclose redemption amounts, THMA traded below $10 throughout its redemption deadline November 26. However, it hit a 52-week high of
Read More